| |
|
|
|
| Data collected prospectively from patients hospitalized with unstable angina or non–Q-wave MI. *Organization to Assess Strategies for Ischemic Syndromes. ... |
|
|
|
|
| Cholesterol levels rechecked within 3 months of initiation. Liver function tests (ALT and AST) checked within first year of therapy. ... |
|
|
|
|
| Cholesterol is a fatty steroid made primarily in the liver of most animals and humans. It is an integral component in the synthesis of hormones, ... |
|
|
|
|
|
Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 2004;350(15):1495–1504. The introduction of statins has ...
|
|
|
|
|
| Inhibiting HMG CoA reductase by administering statins forces cells to get their cholesterol from circulating LDL particles. The cells do so by upregulating … |
|
|
|
|
| British Journal of Ophthalmology 2005;89:1171-1175; doi:10.1136/bjo.2004.064477; A case control study of age related macular degeneration and use of statins … |
|
|
|
|
| Statins have antiatherosclerotic effects, that positively correlate with the percent decrease in LDL cholesterol. In addition, they can exert … |
|
|
|
|
| Efficacy and Safety of Rosuvastatin and Atorvastatin in Patients With Hypercholesterolemia and a High Risk of Coronary Heart Disease: A Randomized, ... |
|
|
|
|
| Use of statins for primary prevention of myocardial infarction and stroke may have additional benefits by reducing risk of epilepsy. ... |
|
|
|
|
| Effectiveness of therapeutic lifestyle changes in patients with hypertension, hyperlipidemia, and/or hyperglycemia. Am J Cardiol. 2004;94:1558-1561. ... |
|
|
